Frank Stokes - 16 Jun 2022 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Director
Signature
/s/ Kamal Adawi, as attorney-in-fact
Issuer symbol
XGN
Transactions as of
16 Jun 2022
Transactions value $
$0
Form type
4
Filing time
21 Jun 2022, 08:32:15 UTC
Previous filing
16 May 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XGN Stock Option(right to buy) Award $0 +9K $0.00 9K 16 Jun 2022 Common Stock 9K $5.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.